Standard & Poor's
http://www2.standardandpoors.comStandard & Poor’s, a division of McGraw-Hill (NYSE: MHP), produces financial research and analysis on stocks and bonds. It provides credit ratings on public and private corporations and is designated as a Nationally Recognized Statistical Rating Organization (NRSRO) by the SEC. The firm’s long-term credit ratings range from “AAA” to “D” and its short-term credit ratings range from “A-1” to “D”. Standard & Poor’s also publishes indexes including the S&P 500.
View Older Stories
-
Netflix (NFLX) PT Raised to $1,400 at Guggenheim
-
Pain trade is index going higher, led by Mag 7 - Goldman Sachs
-
Benchmark Reiterates Hold Rating on Netflix (NFLX)
-
TD Cowen: 'Netflix (NFLX) Well Positioned Despite Macro'
-
MoffettNathanson Upgrades Netflix (NFLX) to Buy
-
Wolfe Research Reiterates Peerperform Rating on Netflix (NFLX)
-
Netflix (NFLX) PT Raised to $950 at Guggenheim
-
Netflix (NFLX) PT Raised to $1,000 at KeyBanc
-
Netflix (NFLX) PT Raised to $680 at Rosenblatt
-
Wolfe Research Reiterates Peerperform Rating on Netflix (NFLX)
-
Netflix (NFLX) PT Raised to $800 at Loop Capital
-
Netflix (NFLX) PT Raised to $810 at Guggenheim
-
How to navigate a concentrated market? Barclays has the answer
-
What makes the S&P 500 pullback worse?
-
Netflix (NFLX) stock is overvalued says Benchmark, sees nearly 30% downside risk
-
Netflix's subscribers, TSMC, Tesla upside - what's moving markets
-
BofA selects 10 growth and 10 value stocks for March
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Are new highs sustainable?
-
Netflix (NFLX) PT Raised to $425 at Benchmark, Maintains Sell, 'Remain Cautious Despite Netflix Stock Price Breakout'
-
Midday movers: Apple, Netflix and more
-
Gaza update, Chinese GDP, Netflix earnings - what's moving markets
-
Netflix (NFLX) falls as analyst downgrades on 'full' expectations for 2024
-
Wolfe Research Downgrades Netflix (NFLX) to Peerperform, 'Advancing From Designated Survivor Takes Patience'
-
Netflix (NFLX) has dreadful day on ad hiccups
-
Futures higher, Senate unveils funding deal - what's moving markets
-
JPMorgan lists 3 reasons why Netflix (NFLX) shares sold off after earnings
-
Dow Jones, Nasdaq, S&P 500 weekly preview: All eyes on Microsoft
-
U.S. stock futures point higher, FTX sues Bankman-Fried - what's moving markets
-
Tesla, Netflix earnings; Apple reportedly tests AI tools - what's moving markets
-
After-hours movers: Netflix falls following EPS, United Airlines gains
-
Goldman Sachs to report, Tesla and Netflix on tap - what's moving markets
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Big Tech takes the stage
-
This internet stock is a new Top Pick at Evercore ISI with upside potential of 75%
-
Netflix and Disney poised to outperform in Q3 says BofA
-
Netflix adds, Fox lawsuit and U.K. inflation - what's moving markets
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Tech takes the earnings stage
-
Alphabet job cuts, Netflix growth, Genesis bankruptcy - what's moving markets
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Investors are positioning for a Fed pivot
-
S&P 500 likely 'flattish' in 2023, Meta Platforms (META) the best mega-cap stock - JPM's survey
-
JPMorgan Calls Meta Platforms (META) 'favorite mega-cap', Says Survey Signals Internet Names to Outperform in 2023
-
Netflix (NFLX) PT Raised to $225 at Benchmark, Stays Sell, 'We remain cautious'
-
Wells Fargo Upgrades Netflix (NFLX) to Overweight, 'More Ways to Win'
-
Microsoft overtakes Amazon as most popular hedge funds long - Goldman
-
Netflix (NFLX) PT Raised to $220 at MoffettNathanson But Says Street May Be Overestimating Ad Tier Upside
-
Netflix (NFLX) Could Get 3x the Advertising ARPU of Hulu Says Atlantic After Upgrades Shares
-
Pre-Open Movers: Akero Doubles on Drug Data, Tech Stocks Fall on Hot CPI
-
Netflix (NFLX) Stock Dips as Analyst Cuts to Sell on Expected Underperformance
-
UPDATE: CFRA Downgrades Netflix (NFLX) to Sell
-
Analysts See Risks For Netflix (NFLX) Ahead of Q2 Results
-
Pre-Open Stock Movers 06/14: Oracle Jumps on Earnings, FedEx Up on Dividend Hike; Outset Medical Falls on FDA Product Hold (more...)

